204
Altimmune, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
193
FY23:
210
FY24:
137
FY25:
278
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.7
FY22:
14.1
FY23:
1.01
FY24:
2.05
FY25:
1.74
Total assets
Change from FY21 to FY25
millions USD
FY21:
219
FY22:
207
FY23:
211
FY24:
139
FY25:
280
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
18.3
FY22:
17.1
FY23:
12.1
FY24:
10.5
FY25:
15.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.45
FY22:
4.58
FY23:
4.40
FY24:
5.33
FY25:
40.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
199
FY22:
185
FY23:
194
FY24:
124
FY25:
225
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
219
FY22:
207
FY23:
211
FY24:
139
FY25:
280
All amounts in millions USD